Skip to content
The Great Grantsby G

EIT Health

Biotech Certified Innovation Path

Up to €240,000| Deadline: 16 September 2026 (3 days)

Call opens 24 June 2026; application platform opens 15 July 2026

Last updated:

Deadline in 3 days. Add it to your calendar, then see what else you're eligible for. See my matches →

The Biotech Certified Innovation Path, funded by EIT Health, supports consortia to design and deliver certified personalised learning courses in health biotechnology covering innovation, entrepreneurship, and translational expertise. Awards up to €240,000 per project to teams of at least two higher education institutions (HEIs) across different EU Member States plus at least one industry or non-academic partner. This is a one-off call emphasising multi-disciplinary, cross-border curriculum development with EIT Label certification and ECTS credit accreditation.

Details

Funder EIT Health
Budget Up to €240,000
Deadline 16 September 2026
Consortium Required — minimum two Higher Education Institutions from two different eligible Member States, at least one in an EIT RIS region, plus at least one non-academic/industry partner
Application Single stage
Frequency One-off

Eligibility & scope

Funds development of an EIT Label-certified Biotech pathway within the Certified Innovation Path portfolio, designing personalised learning courses covering EU Biotech Act, Clinical Trials Regulation and MDR/IVDR translation and scale-up. Requires consortium of HEIs (one authorised to award ECTS credits) plus active industry/non-academic partner involvement in curriculum and assessment.

Who Should Apply

  • •Consortia of at least 2 HEIs from different eligible EU Member States (at least one in an EIT RIS region)
  • •At least one HEI with authority to award ECTS credits
  • •Teams including at least one industry partner or non-academic organisation
  • •Institutions ready to collaborate on EIT Label-certified course design and delivery in biotechnology

Key Dates

  • •Application platform opens 15 July 2026; deadline 16 September 2026
  • •Single-stage evaluation

Tips for Applicants

  • ✓EIT RIS eligibility is gating, at least one HEI must be in an EIT Regional Innovation Scheme region; verify your partner institution's status before submitting.
  • ✓ECTS accreditation is non-negotiable; ensure one partner has the regulatory authority to award credits and confirms this in writing.
  • ✓The industry partner's letter should outline their role in course design and delivery, not just endorsement; EIT Health values hands-on engagement from the non-academic sector.

Frequently Asked Questions

How much funding does the Biotech Certified Innovation Path provide?

Up to €240,000 per project.

Who must be part of the consortium for the Biotech Certified Innovation Path?

At least 2 HEIs from different eligible EU Member States (one in an EIT RIS region), plus at least 1 industry or non-academic partner; at least one HEI must be authorised to award ECTS credits.

What type of course does the Biotech Certified Innovation Path fund?

EIT Label-certified personalised learning courses in health biotechnology covering innovation, entrepreneurship, and translational or regulatory expertise.

Is the Biotech Certified Innovation Path a recurring call?

No, this is a one-off call.

When does the application platform open for the Biotech Certified Innovation Path?

The platform opens on 15 July 2026, with a deadline of 16 September 2026.

eit-healthbiotechnologycurriculum-developmentconsortium-requiredentrepreneurshipcross-bordercertification
View full call →
Share ✉ Email X LinkedIn WhatsApp

Summary generated by AI based on published grant information. Always verify details on the funder's website.

Similar grants

Browse all open grants →

Browse Related

Closing in September 2026

Could Biotech Certified Innovation Path be right for you?

Deadline in 3 days. See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.

See my matches free →